Growth Metrics

Sonoma Pharmaceuticals (SNOA) Deferred Taxes (2022 - 2025)

Sonoma Pharmaceuticals has reported Deferred Taxes over the past 4 years, most recently at -$93000.0 for Q2 2025.

  • For Q2 2025, Deferred Taxes rose 23.77% year-over-year to -$93000.0; the TTM value through Jun 2025 reached -$328000.0, down 525.97%, while the annual FY2025 figure was -$357000.0, 427.52% down from the prior year.
  • Deferred Taxes for Q2 2025 was -$93000.0 at Sonoma Pharmaceuticals, up from -$188000.0 in the prior quarter.
  • Over five years, Deferred Taxes peaked at $829000.0 in Q1 2022 and troughed at -$188000.0 in Q1 2025.
  • A 4-year average of $37500.0 and a median of -$60000.0 in 2023 define the central range for Deferred Taxes.
  • Biggest five-year swings in Deferred Taxes: skyrocketed 149.52% in 2023 and later crashed 193.53% in 2025.
  • Year by year, Deferred Taxes stood at -$105000.0 in 2022, then skyrocketed by 149.52% to $52000.0 in 2023, then tumbled by 63.46% to $19000.0 in 2024, then crashed by 589.47% to -$93000.0 in 2025.
  • Business Quant data shows Deferred Taxes for SNOA at -$93000.0 in Q2 2025, -$188000.0 in Q1 2025, and $19000.0 in Q4 2024.